Drawing for SYNBIOFF

USPTO serial 79338517

SYNBIOFF

Reviewed by CopyMark Law Group

Reg. 7220430Status 700Registered
Filing date
Status date
Registration date
Nov 21, 2023
Examiner
COLEMAN, CIMMERIAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SYNBIOFF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert S. Broder

Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Probiotic bacteria for use in the manufacture of pharmaceuticals and nutraceuticalsACTIVE—
005Probiotic bacterial formulations for medical use; probiotic supplements; pharmaceutical and medicinal preparations for use in the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical and medicinal preparations for use in the treatment of gastro-intestinal, immunity and uro-genital disorders, hyperlipidemia, sunburn, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, damaged skin and tissue, eye diseases and conditions, skin disorders, diabetes, erectile dysfunction, bone diseases, immune system related diseases and disorders, allergies, hypertension, epidermis, respiratory diseases, cardiovascular disorders, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, respiratory diseases, asthma, allergic rhinitis, viral infections, gastro-intestinal diseases, halitosis, viral diseases, autoimmune diseases; pharmaceutical preparations for skin care; pharmaceutical preparations for use in urology; pharmaceutical preparations for the prevention of gastro-intestinal and urogenital infections, seasonal illness, common colds, cardiovascular disease, gastro-intestinal or local dysbiosis, allergies; pharmaceutical preparations for wounds; pharmaceutical preparations for animal skincare; pharmaceutical preparations acting on the central nervous system; dermatological pharmaceutical products; pharmaceutical skin lotions; pharmaceutical products for skin care for animals; anti-diabetic pharmaceuticals; ferments for pharmaceutical purposes; pharmaceutical agents affecting metabolism; ferments for pharmaceutical purposes, namely, for gastro-intestinal, immunity and uro-genital disorders; digestives for pharmaceutical purposes; pharmaceutical preparation for skin care; pharmaceuticals, namely, lipid lowering agents; milk ferments for pharmaceutical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 18, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 22, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 22, 2024FIMPFINAL DISPOSITION PROCESSED—
Feb 21, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 21, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 21, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 16, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 27, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 27, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 5, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 5, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 4, 2023GPNXNOTIFICATION PROCESSED BY IB—
Aug 16, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 16, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 16, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 14, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 15, 2023RFNTREFUSAL PROCESSED BY IB—
Feb 22, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 22, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 27, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 26, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2022DOCKASSIGNED TO EXAMINER—
Apr 26, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 22, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 21, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance